DCF ADVISERS, LLC – Revance Therapeutics, Inc. Transaction History
DCF ADVISERS, LLC portfolio value:
$0
portfolio value
DCF ADVISERS, LLC quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -12K shares | -166K | $27 | 0 |
| Q2 2022 | share | Increase | 0.00% | 12K shares | 166K | $13.82 | 12K |